The global In Vitro Diagnostics (IVD) market size is expected to hit around USD 125.78 billion by 2030 and progressing a CAGR of 4.94% over the forecast period 2022 to 2030.
The on In
Vitro Diagnostics (IVD) Market, which provides a business strategy, research
& development activities, concise outline of the market valuation, valuable
insights pertaining to market share, size, supply chain analysis, competitive
landscape and regional proliferation of this industry.
Download
Free Sample@ https://www.precedenceresearch.com/sample/1130
Scope of the In Vitro Diagnostics Market Report
| Report Coverage | Details |
| Market Size | USD 125.78 Billion by 2030 |
| Growth Rate | CAGR of 4.94% from 2022 to 2030 |
| Base Year | 2022 |
| Historic Data | 2020 to 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | Product, Technology, Application |
| Regional Scope | North America, APAC, Europe, Latin America, MEAN, Rest of the World |
A recent
report provides crucial insights along with application based and forecast
information in the Global In Vitro Diagnostics (IVD) Market. The report
provides a comprehensive analysis of key factors that are expected to drive the
growth of this market. This study also provides a detailed overview of the
opportunities along with the current trends observed in the In Vitro
Diagnostics (IVD) market.
A
quantitative analysis of the industry is compiled for a period of 10 years in
order to assist players to grow in the market. Insights on specific revenue
figures generated are also given in the report, along with projected revenue at
the end of the forecast period.
Companies
and Manufacturers Covered
The study
covers key players operating in the market along with prime schemes and
strategies implemented by each player to hold high positions in the industry.
Such a tough vendor landscape provides a competitive outlook of the industry,
consequently existing as a key insight. These insights were thoroughly analysed
and prime business strategies and products that offer high revenue generation
capacities were identified. Key players of the global In Vitro Diagnostics
(IVD) market are included as given below:
In Vitro Diagnostics (IVD) Market Key Players
- Alere, Inc.
- Hoffmann-La Roche Ltd.
- Arkray
- Beckman Coulter
- Becton Disckinson
- Bio-Rad laboratories
- Danaher
- Sysmex Corporation
- Abbott Laboratories
Market Segments
- Reagents
- Instruments
- Services
By Test Location
- Point of Care
- Home Care
- Others
By Technology
Immunoassay
Instruments
Reagents
Services
Hematology
Instruments
Reagents
Services
Clinical Chemistry
Instruments
Reagents
Services
Molecular Diagnostics
Instruments
Reagents
Services
Coagulation
Instruments
Reagents
Services
Microbiology
Instruments
Reagents
Services
Others
Instruments
Reagents
Services
By Application
- Diabetes
- Cardiology
- Nephrology
- Infectious Disease
- Oncology
- Drug Testing
- Autoimmune Diseases
- Others
By End User
- Standalone Laboratories
- Hospitals
- Academic & Medical Schools
- Point-of-Care
- Others
By Regional
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia Pacific
- China
- India
- Japan
- South Korea
- Middle East & Africa
- Latin America
Report Objectives
- To define, describe, and forecast the global In Vitro Diagnostics
(IVD) market based on product, and region
- To provide detailed information regarding the major
factors influencing the growth of the market (drivers, opportunities, and
industry-specific challenges)
- To strategically analyze micromarkets1 with respect to
individual growth trends, future prospects, and contributions to the total
market
- To analyze opportunities in the market for stakeholders
and provide details of the competitive landscape for market leaders
- To forecast the size of market segments with respect to
four main regions—North America,
Europe, Asia Pacific and the Rest of the World (RoW)2
- To strategically profile key players and comprehensively
analyze their product portfolios, market shares, and core competencies3
- To track and analyze competitive developments such as
acquisitions, expansions, new product launches, and partnerships in the In
Vitro Diagnostics (IVD) market
Table of Content
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. In Vitro Diagnostics (IVD) Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
Chapter 5. COVID 19 Impact on In Vitro Diagnostics (IVD) Market
5.1. Covid-19: In Vitro Diagnostics (IVD) Industry Impact
5.2. In Vitro Diagnostics (IVD) Business Impact Assessment: Covid-19
5.2.1. Supply Chain Challenges/Disruption
5.2.2. Market Trends and In Vitro Diagnostics (IVD) Opportunities in the COVID-19 Landscape
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for In Vitro Diagnostics (IVD) Manufacturers to deal with Covid-19 Pandemic Scenario
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Global In Vitro Diagnostics (IVD) Market: Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. In Vitro Diagnostics (IVD) Market Revenue by Manufacturer (2017-2021)
7.1.1.2. In Vitro Diagnostics (IVD) Market Revenue Market Share by Manufacturer (2017-2021)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Capacity Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global In Vitro Diagnostics (IVD) Market, By Product Type
8.1. In Vitro Diagnostics (IVD) Market, by Product Type, 2017-2030
8.1.1. Reagents
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Instruments
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Services
8.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global In Vitro Diagnostics (IVD) Market, By Technology
9.1. In Vitro Diagnostics (IVD) Market, By Technology, 2017-2030
9.1.1. Hematology
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Molecular Diagnostics
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Immunology
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Coagulation
9.1.4.1. Market Revenue and Forecast (2017-2030)
9.1.5. Clinical Chemistry
9.1.5.1. Market Revenue and Forecast (2017-2030)
9.1.6. Microbiology
9.1.6.1. Market Revenue and Forecast (2017-2030)
9.1.7. Other
9.1.7.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global In Vitro Diagnostics (IVD) Market, By Application
10.1. In Vitro Diagnostics (IVD) Market, By Application, 2017-2030
10.1.1. Diabetes
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Cardiology
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Nephrology
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Infectious Disease
10.1.4.1. Market Revenue and Forecast (2017-2030)
10.1.5. Oncology
10.1.5.1. Market Revenue and Forecast (2017-2030)
10.1.6. Drug Testing
10.1.6.1. Market Revenue and Forecast (2017-2030)
10.1.7. Autoimmune Diseases
10.1.7.1. Market Revenue and Forecast (2017-2030)
10.1.8. Others
10.1.8.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global In Vitro Diagnostics (IVD) Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue Forecast by Product (2017-2030)
11.1.2. Market Revenue Forecast By Technology (2017-2030)
11.1.3. Market Revenue Forecast By Application (2017-2030)
11.1.4. Market Revenue Forecast by Technology (2017-2030)
11.1.5. U.S
11.1.5.1. Market Revenue Forecast (2017-2030)
11.1.5.2. Market Revenue Forecast (2017-2030)
11.1.6. Canada
11.1.6.1. Market Revenue Forecast (2017-2030)
11.1.6.2. Market Revenue Forecast (2017-2030)
11.2. Europe
11.2.1. Market Revenue Forecast by Product (2017-2030)
11.2.2. Market Revenue Forecast By Technology (2017-2030)
11.2.3. Market Revenue Forecast By Application (2017-2030)
11.2.4. Market Revenue Forecast by Technology (2017-2030)
11.2.5. UK
11.2.5.1. Market Revenue Forecast (2017-2030)
11.2.5.2. Market Revenue Forecast (2017-2030)
11.2.6. Germany
11.2.6.1. Market Revenue Forecast (2017-2030)
11.2.6.2. Market Revenue Forecast (2017-2030)
11.2.7. France
11.2.7.1. Market Revenue Forecast (2017-2030)
11.2.7.2. Market Revenue Forecast (2017-2030)
11.2.8. Rest of EU
11.2.8.1. Market Revenue Forecast (2017-2030)
11.2.8.2. Market Revenue Forecast (2017-2030)
11.3. Asia Pacific (APAC)
11.3.1. Market Revenue Forecast by Product (2017-2030)
11.3.2. Market Revenue Forecast By Technology (2017-2030)
11.3.3. Market Revenue Forecast By Application (2017-2030)
11.3.4. Market Revenue Forecast by Technology (2017-2030)
11.3.5. China
11.3.5.1. Market Revenue Forecast (2017-2030)
11.3.5.2. Market Revenue Forecast (2017-2030)
11.3.6. India
11.3.6.1. Market Revenue Forecast (2017-2030)
11.3.6.2. Market Revenue Forecast (2017-2030)
11.3.7. Japan
11.3.7.1. Market Revenue Forecast (2017-2030)
11.3.7.2. Market Revenue Forecast (2017-2030)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue Forecast (2017-2030)
11.3.8.2. Market Revenue Forecast (2017-2030)
11.4. LATAM
11.4.1. Market Revenue Forecast by Product (2017-2030)
11.4.2. Market Revenue Forecast By Technology (2017-2030)
11.4.3. Market Revenue Forecast By Application (2017-2030)
11.4.4. Market Revenue Forecast by Technology (2017-2030)
11.4.5. Brazil
11.4.5.1. Market Revenue Forecast (2017-2030)
11.4.5.2. Market Revenue Forecast (2017-2030)
11.4.6. Rest of LATAM
11.4.6.1. Market Revenue Forecast (2017-2030)
11.4.6.2. Market Revenue Forecast (2017-2030)
11.5. Middle East and Africa (MEA)
11.5.1. Market Revenue Forecast by Product (2017-2030)
11.5.2. Market Revenue Forecast By Technology (2017-2030)
11.5.3. Market Revenue Forecast By Application (2017-2030)
11.5.4. Market Revenue Forecast by Technology (2017-2030)
11.5.5. GCC
11.5.5.1. Market Revenue Forecast (2017-2030)
11.5.5.2. Market Revenue Forecast (2017-2030)
11.5.6. North Africa
11.5.6.1. Market Revenue Forecast (2017-2030)
11.5.6.2. Market Revenue Forecast (2017-2030)
11.5.7. South Africa
11.5.7.1. Market Revenue Forecast (2017-2030)
11.5.7.2. Market Revenue Forecast (2017-2030)
11.5.8. Rest of MEA
11.5.8.1. Market Revenue Forecast (2017-2030)
11.5.8.2. Market Revenue Forecast (2017-2030)
Chapter 12. Company Profiles
12.1. Alere, Inc.
12.1.1. Company Overview, Business Information, Manufacturing Area
12.1.2. Product Portfolio Analysis
12.1.2.1. Product Details, Specification, Application
12.1.3. Revenue and Gross Margin (2017-2021)
12.1.4. Recent Developments and Strategies
12.2. Hoffmann-La Roche Ltd.
12.2.1. Company Overview, Business Information, Manufacturing Area
12.2.2. Product Portfolio Analysis
12.2.2.1. Product Details, Specification, Application
12.2.3. Revenue and Gross Margin (2017-2021)
12.2.4. Recent Developments and Strategies
12.3. Arkray
12.3.1. Company Overview, Business Information, Manufacturing Area
12.3.2. Product Portfolio Analysis
12.3.2.1. Product Details, Specification, Application
12.3.3. Revenue and Gross Margin (2017-2021)
12.3.4. Recent Developments and Strategies
12.4. Beckman Coulter
12.4.1. Company Overview, Business Information, Manufacturing Area
12.4.2. Product Portfolio Analysis
12.4.2.1. Product Details, Specification, Application
12.4.3. Revenue and Gross Margin (2017-2021)
12.4.4. Recent Developments and Strategies
12.5. Becton Disckinson
12.5.1. Company Overview, Business Information, Manufacturing Area
12.5.2. Product Portfolio Analysis
12.5.2.1. Product Details, Specification, Application
12.5.3. Revenue and Gross Margin (2017-2021)
12.5.4. Recent Developments and Strategies
12.6. Bio-Rad laboratories
12.6.1. Company Overview, Business Information, Manufacturing Area
12.6.2. Product Portfolio Analysis
12.6.2.1. Product Details, Specification, Application
12.6.3. Revenue and Gross Margin (2017-2021)
12.6.4. Recent Developments and Strategies
12.7. bioMerieux S.A.
12.7.1. Company Overview, Business Information, Manufacturing Area
12.7.2. Product Portfolio Analysis
12.7.2.1. Product Details, Specification, Application
12.7.3. Revenue and Gross Margin (2017-2021)
12.7.4. Recent Developments and Strategies
12.8. Danaher
12.8.1. Company Overview, Business Information, Manufacturing Area
12.8.2. Product Portfolio Analysis
12.8.2.1. Product Details, Specification, Application
12.8.3. Revenue and Gross Margin (2017-2021)
12.8.4. Recent Developments and Strategies
12.9. Sysmex Corporation
12.9.1. Company Overview, Business Information, Manufacturing Area
12.9.2. Product Portfolio Analysis
12.9.2.1. Product Details, Specification, Application
12.9.3. Revenue and Gross Margin (2017-2021)
12.9.4. Recent Developments and Strategies
12.10. Abbott Laboratories
12.10.1. Company Overview, Business Information, Manufacturing Area
12.10.2. Product Portfolio Analysis
12.10.2.1. Product Details, Specification, Application
12.10.3. Revenue and Gross Margin (2017-2021)
12.10.4. Recent Developments and Strategies
12.11. Company 11
12.11.1. Company Overview, Business Information, Manufacturing Area
12.11.2. Product Portfolio Analysis
12.11.2.1. Product Details, Specification, Application
12.11.3. Revenue and Gross Margin (2017-2021)
12.11.4. Recent Developments and Strategies
12.12. Company 12
12.12.1. Company Overview, Business Information, Manufacturing Area
12.12.2. Product Portfolio Analysis
12.12.2.1. Product Details, Specification, Application
12.12.3. Revenue and Gross Margin (2017-2021)
12.12.4. Recent Developments and Strategies
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
0 Comments